LifeStance Health Group (NASDAQ:LFST) COO Lisa Miller Sells 14,663 Shares of Stock

Key Points

• COO Lisa Miller sold 14,663 shares for about $215,253, reducing her position by 5.5% to 251,904 shares. The sale covered tax withholding on vested equity awards.
• LifeStance reported quarterly EPS of $0.06 versus analysts’ $0.04 estimate, while revenue of $455.9 million beat forecasts and rose 25.3% year over year.
• Analysts’ consensus rating is Moderate Buy, with a $14 average price target; shares recently traded at $14.15.

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) COO Lisa Miller sold 14,663 shares of the business's stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $14.68, for a total value of $215,252.84. Following the transaction, the chief operating officer owned 251,904 shares of the company's stock, valued at $3,697,950.72. This trade represents a 5.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

LifeStance Health Group Trading Down 1.5%

Shares of LFST traded down $0.22 during mid-day trading on Thursday, reaching $14.15. 5,017,661 shares of the company's stock traded hands, compared to its average volume of 3,932,527. The stock has a market cap of $5.38 billion, a P/E ratio of 74.48 and a beta of 1.35. The stock's 50-day moving average is $12.74 and its two-hundred day moving average is $9.60. LifeStance Health Group, Inc. has a 12 month low of $6.01 and a 12 month high of $15.66. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.44 and a quick ratio of 1.44.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. LifeStance Health Group had a return on equity of 4.82% and a net margin of 4.29%. The firm had revenue of $455.86 million during the quarter, compared to analyst estimates of $431.59 million. LifeStance Health Group's quarterly revenue was up 25.3% compared to the same quarter last year. Research analysts forecast that LifeStance Health Group, Inc. will post 0.18 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on LFST. KeyCorp lifted their target price on LifeStance Health Group from $15.00 to $17.00 and gave the stock an "overweight" rating in a research report on Friday, November 6th. Barclays upped their price target on shares of LifeStance Health Group from $13.00 to $15.00 and gave the stock an "overweight" rating in a report on Thursday, September 10th. Wall Street Zen lowered shares of LifeStance Health Group from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 5th. Canaccord Genuity Group boosted their price objective on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a "buy" rating in a research report on Friday, November 6th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of LifeStance Health Group in a research note on Wednesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $14.00.

Institutional Trading of LifeStance Health Group

Hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in shares of LifeStance Health Group in the 2nd quarter valued at about $389,293,000. Dimensional Fund Advisors LP increased its holdings in LifeStance Health Group by 16.4% during the first quarter. Dimensional Fund Advisors LP now owns 10,367,680 shares of the company's stock valued at $66,038,000 after buying an additional 1,461,215 shares during the period. Jennison Associates LLC increased its holdings in LifeStance Health Group by 38.5% during the first quarter. Jennison Associates LLC now owns 10,228,801 shares of the company's stock valued at $65,157,000 after buying an additional 2,843,388 shares during the period. Voya Investment Management LLC increased its holdings in LifeStance Health Group by 1,249.6% during the third quarter. Voya Investment Management LLC now owns 3,971,989 shares of the company's stock valued at $47,783,000 after buying an additional 3,677,679 shares during the period. Finally, Wellington Management Group LLP bought a new position in LifeStance Health Group in the second quarter worth approximately $30,881,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance's clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.